関連する実験動画
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
卵の消費と心不全のリスクは,医師の健康調査で明らかになった
Luc Djoussé1, J Michael Gaziano
1Division of Aging, Brigham and Women's Hospital and Harvard Medical School, 1620 Tremont St, Third Floor, Boston MA 02120, USA. ldjousse@rics.bwh.harvard.edu
Circulation
|January 16, 2008
まとめ
1日1個以上の卵を食べると,男性では心不全のリスクが増加する可能性があります. 卵を頻繁に摂取することは,心不全 (HF) のリスクと関連していません.
科学分野:
- 心血管疾患の流行病学について
- 栄養科学とは,栄養科学である.
- クリニック・リサーチ 臨床研究
背景:
- 心血管疾患の予防のために,食事中のコレステロールの減少が推奨されています.
- 卵は栄養が豊富ですが,心不全 (HF) リスクとの関連は不明です.
- 卵の消費がHFに与える影響を理解することは,公衆衛生上の勧告にとって極めて重要です.
研究 の 目的:
- 卵の消費とインシデント心不全 (HF) のリスクとの関連を調査する.
- 大量の卵の摂取がHFを発症するリスクをもたらすかどうかを判断する.
- 心血管の健康のためのダイエットガイドラインに関する証拠に基づいた洞察を提供する.
主な方法:
- 21,275人の男性医師を対象とした前向きなコホート研究.
- 食事頻度アンケートで評価された卵の消費量.
- コックス回帰分析は,多重心血管疾患のリスク要因を調整したHFリスクを推定するために使用されました.
主要な成果:
- 週6回までの卵の摂取でHFリスクの増加は観察されなかった.
- 週7回以上の卵の摂取は,HFのリスクの増加と関連していました.
- 1日1個の卵を摂取するとHFのリスクが28%増加し,2個以上の卵を毎日摂取すると64%増加しました.
結論:
- 卵の頻度の低い消費は,HFリスクに関して安全であるように思われる.
- 日々の卵の摂取 (≥1日) は,米国の男性医師の心不全のリスクが高いことと関連しています.
- 研究結果は,心臓血管の健康管理のために,毎日の卵摂取量を控えることを示唆しています.
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K